Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P8
Near historical low
vs 5Y Ago
-2.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-150.49%
202326.95%
202254.42%
20210.00%
2020100.00%
201958.95%
2018-383.04%
2017186.38%
2016-46.05%
201535.67%